Evidence map›Paper›PMID 35059506›Full record

ReviewHealth science reports2022

The importance of myocarditis in Covid-19.

Katayoun Haryalchi, Sepehr Olangian-Tehrani, Seyed Mohammad Asgari Galebin, Mandana Mansour-Ghanaie

Open access · goldAbstract readReview
In one paragraph

Review in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. The importance of myocarditis in Covid-19.Health science reports · 2022
    Review
  4. Article
  5. Can COVID-19 vaccines improve cardiovascular outcomes?Travel medicine and infectious disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Katayoun HaryalchiReproductive Health Research Center, Al-zahra Hospital, School of Medicine Guilan University of Medical Sciences Rasht Iran.ORCID https://orcid.org/0000-0001-8012-9952
Sepehr Olangian-TehraniSchool of Medicine Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-8970-9344
Seyed Mohammad Asgari GalebinSchool of Medicine Guilan University of Medical Sciences Rasht Iran.ORCID https://orcid.org/0000-0002-6464-197X
Mandana Mansour-GhanaieReproductive Health Research Center, Department of Obstetrics & Gynecology, Al-zahra Hospital, School of Medicine Guilan University of Medical Sciences Rasht Iran.ORCID https://orcid.org/0000-0003-1503-3502
Guilan University of Medical Sciences · IRIran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe outbreak of Covid-19 is a real threat to public health. It causes cardiovascular complications such as acute myocardial injury and myocarditis. Symptoms of myocarditis vary from chest pain, tachycardia, or chest tightness. Inotropes and/or vasopressors and mechanical ventilation are the protocols for cardiogenic shock in patients with myocarditis. Some previous studies stated that the mechanism of cardiac injury is not well defined but, it can be due to direct myocardial infection, respiratory failure or hypoxemia, and indirect injury from systemic inflammatory response separately or all three factors together. The pathologic processes included direct myocardial injury by virus binding to ACE2, systemic inflammation, altered myocardial demand-supply ratio, and plaque and coronary thrombosis. There are disagreements on the usage of corticosteroids in active-infection myocarditis. As everyday new complications of Covid-19 appear, there is a need for further research to overcome them.

aimsThis narrative study aimed to assess the effect of Covid-19 on myocarditis.

Indexed as

Covid‐19heartmyocarditis

Identifiers

PMID35059506
PMCPMC8757483
OpenAlexW4206793435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.